Cargando…
The Comprehensive Analysis of Efficacy and Safety of CalliSpheres(®) Drug-Eluting Beads Transarterial Chemoembolization in 367 Liver Cancer Patients: A Multiple-Center, Cohort Study
This study aimed to investigate the efficacy, safety, and prognostic factors of drug-eluting beads transarterial chemoembolization (DEB-TACE) in treating Chinese patients with liver cancer. A total of 367 liver cancer patients from 24 medical centers were consecutively enrolled in this multiple-cent...
Autores principales: | Peng, Zhiyi, Cao, Guohong, Hou, Qinming, Li, Ling, Ying, Shihong, Sun, Junhui, Zhou, Guanhui, Zhou, Jian, Zhang, Xin, Ji, Wenbin, Yu, Zhihai, Li, Tiefeng, Zhu, Dedong, Hu, Wenhao, Ji, Jiansong, Du, Haijun, Shi, Changsheng, Guo, Xiaohua, Fang, Jian, Han, Jun, Gu, Wenjiang, Xie, Xiaoxi, Sun, Zhichao, Xu, Huanhai, Wu, Xia, Hu, Tingyang, Huang, Jing, Hu, Hongjie, Zheng, Jiaping, Luo, Jun, Chen, Yutang, Yu, Wenqiang, Shao, Guoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851534/ https://www.ncbi.nlm.nih.gov/pubmed/31856933 http://dx.doi.org/10.3727/096504019X15766663541105 |
Ejemplares similares
-
Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres(®) in 275 Hepatocellular Carcinoma Patients: Results From the Chinese CalliSpheres(®) Transarterial Chemoembolization in Liver Cancer (CTILC) Study
por: Sun, Junhui, et al.
Publicado: (2020) -
Efficacy and safety of CalliSpheres(®) drug-eluting beads transarterial chemoembolization in patients with secondary liver cancer: a preliminary result from CTILC study
por: Wu, Xia, et al.
Publicado: (2019) -
Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC study
por: Luo, Jun, et al.
Publicado: (2020) -
Oxaliplatin Eluting CalliSpheres Microspheres for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
por: Bi, Yonghua, et al.
Publicado: (2022) -
Efficacy of CalliSpheres® microspheres versus conventional transarterial chemoembolization in the treatment of refractory colorectal cancer liver metastasis
por: Li, Haitao, et al.
Publicado: (2023)